Italfarmaco
Clinical trials sponsored by Italfarmaco, explained in plain language.
-
Hope for DMD: Long-Term givinostat trial now recruiting
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of the drug givinostat in people with Duchenne muscular dystrophy (DMD) who have already taken part in earlier givinostat studies. About 206 participants will take the drug for an extended period to monitor side effects a…
Phase: PHASE2, PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
New hope for blood cancer patients: givinostat takes on standard therapy
Disease control Recruiting nowThis study tests a new drug, givinostat, against the current standard treatment hydroxyurea in 220 adults with a high-risk form of polycythemia vera, a blood cancer that increases red blood cells. The goal is to see if givinostat better controls blood counts and spleen size witho…
Phase: PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated May 14, 2026 12:05 UTC